DNA damage and the balance between survival and death in cancer biology

DNA is vulnerable to damage resulting from endogenous metabolites, environmental and dietary carcinogens, some anti-inflammatory drugs, and genotoxic cancer therapeutics. Cells respond to DNA damage by activating complex signalling networks that decide cell fate, promoting not only DNA repair and survival but also cell death. The decision between cell survival and death following DNA damage rests on factors that are involved in DNA damage recognition, and DNA repair and damage tolerance, as well as on factors involved in the activation of apoptosis, necrosis, autophagy and senescence. The pathways that dictate cell fate are entwined and have key roles in cancer initiation and progression. Furthermore, they determine the outcome of cancer therapy with genotoxic drugs. Understanding the molecular basis of these pathways is important not only for gaining insight into carcinogenesis, but also in promoting successful cancer therapy. In this Review, we describe key decision-making nodes in the complex interplay between cell survival and death following DNA damage.

[1]  Y. Suh,et al.  Regulated Degradation of Chk1 by chaperone-mediated autophagy in response to DNA damage , 2015, Nature Communications.

[2]  Y. Miki,et al.  DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage. , 2007, Molecular cell.

[3]  F. Palitti,et al.  Transcription coupled repair efficiency determines the cell cycle progression and apoptosis after UV exposure in hamster cells. , 2002, DNA repair.

[4]  A. Winoto,et al.  Fas-associated death domain (FADD) is a negative regulator of T-cell receptor–mediated necroptosis , 2010, Proceedings of the National Academy of Sciences.

[5]  Jeffrey S. Smith.  Human Sir2 and the 'silencing' of p53 activity. , 2002, Trends in cell biology.

[6]  Reham Atteya,et al.  Topoisomerase-mediated chromosomal break repair: an emerging player in many games , 2015, Nature Reviews Cancer.

[7]  F. D. D. Fagagna,et al.  Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation , 2012, Nature Cell Biology.

[8]  Y. Tsujimoto,et al.  Another way to die: autophagic programmed cell death , 2005, Cell Death and Differentiation.

[9]  F. Fuller-Pace,et al.  The RNA helicase p68 (DDX5) is selectively required for the induction of p53-dependent p21 expression and cell cycle arrest after DNA damage , 2012, Oncogene.

[10]  J. Hoeijmakers,et al.  Understanding nucleotide excision repair and its roles in cancer and ageing , 2014, Nature Reviews Molecular Cell Biology.

[11]  M. Christmann,et al.  Long‐term activation of SAPK/JNK, p38 kinase and fas‐L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance , 2004, International journal of cancer.

[12]  J. Diebold,et al.  Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. , 1998, The American journal of pathology.

[13]  T. Hofmann,et al.  Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR , 2008, Nature Cell Biology.

[14]  G. Downey,et al.  Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. , 2007, Free radical biology & medicine.

[15]  D. Durocher,et al.  MRE11 promotes AKT phosphorylation in direct response to DNA double-strand breaks , 2011, Cell cycle.

[16]  E. Miller,et al.  Mechanisms of chemical carcinogenesis , 1981, Cancer.

[17]  W. Gerald,et al.  Inactivation of the apoptosis effector Apaf-1 in malignant melanoma , 2001, Nature.

[18]  P. Chambon,et al.  Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[19]  B. Kaina,et al.  Intrinsic anticancer drug resistance of malignant melanoma cells is abrogated by IFN-β and valproic acid. , 2011, Cancer research.

[20]  Francesca Storici,et al.  Differential Transactivation by the p53 Transcription Factor Is Highly Dependent on p53 Level and Promoter Target Sequence , 2002, Molecular and Cellular Biology.

[21]  B. Kaina,et al.  Apoptosis induced by DNA damage O6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/caspase-8 independent. , 2000, Cancer research.

[22]  Michael D. Schneider,et al.  Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy , 2005, Cell.

[23]  M. Christmann,et al.  A role for UV-light-induced c-Fos: Stimulation of nucleotide excision repair and protection against sustained JNK activation and apoptosis. , 2007, Carcinogenesis.

[24]  C. Y. Wang,et al.  NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. , 1998, Science.

[25]  K. Blomgren,et al.  Apoptosis-inducing factor deficiency decreases the proliferation rate and protects the subventricular zone against ionizing radiation , 2010, Cell Death and Disease.

[26]  Z. Ronai,et al.  The Ubiquitin Ligase Siah2 and the Hypoxia Response , 2009, Molecular Cancer Research.

[27]  M. Weller,et al.  Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine , 2007, Oncogene.

[28]  Albert J. Fornace,et al.  Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity , 2002, Nature Genetics.

[29]  S. Ichwan,et al.  Defect in serine 46 phosphorylation of p53 contributes to acquisition of p53 resistance in oral squamous cell carcinoma cells , 2006, Oncogene.

[30]  M. Christmann,et al.  Human monocytes are severely impaired in base and DNA double-strand break repair that renders them vulnerable to oxidative stress , 2011, Proceedings of the National Academy of Sciences.

[31]  B. Kaina,et al.  Contribution of ATM and ATR to the Resistance of Glioblastoma and Malignant Melanoma Cells to the Methylating Anticancer Drug Temozolomide , 2013, Molecular Cancer Therapeutics.

[32]  L. Virág,et al.  Poly(ADP-ribose) signaling in cell death. , 2013, Molecular aspects of medicine.

[33]  G. Wondrak,et al.  Autophagic-lysosomal dysregulation downstream of cathepsin B inactivation in human skin fibroblasts exposed to UVA , 2012, Photochemical & Photobiological Sciences.

[34]  Bernd Kaina,et al.  c-Fos is involved in the cellular defence against the genotoxic effect of UV radiation. , 1995, Carcinogenesis.

[35]  S. Sykes,et al.  The p53 family and programmed cell death , 2008, Oncogene.

[36]  T. Hofmann,et al.  Apoptosis and autophagy: Regulation of apoptosis by DNA damage signalling – roles of p53, p73 and HIPK2 , 2009, The FEBS journal.

[37]  P. Elliott,et al.  Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition. , 2001, Cancer research.

[38]  E. Robertson,et al.  Ubiquitin/SUMO Modification Regulates VHL Protein Stability and Nucleocytoplasmic Localization , 2010, PloS one.

[39]  L. Samson,et al.  Balancing repair and tolerance of DNA damage caused by alkylating agents , 2012, Nature Reviews Cancer.

[40]  Min He,et al.  A role for c-FLIPL in the regulation of apoptosis, autophagy, and necroptosis in T lymphocytes , 2012, Cell Death and Differentiation.

[41]  L. Komuves,et al.  Activity of Protein Kinase RIPK3 Determines Whether Cells Die by Necroptosis or Apoptosis , 2014, Science.

[42]  Thomas Helleday,et al.  DNA repair pathways as targets for cancer therapy , 2008, Nature Reviews Cancer.

[43]  H. O’Hagan,et al.  RPA and ATR link transcriptional stress to p53 , 2007, Proceedings of the National Academy of Sciences.

[44]  K. Kersse,et al.  Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria , 2010, Cell Death and Disease.

[45]  D. Altieri,et al.  A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma , 1997, Nature Medicine.

[46]  P. Vandenabeele,et al.  Molecular mechanisms of necroptosis: an ordered cellular explosion , 2010, Nature Reviews Molecular Cell Biology.

[47]  A. Dipple,et al.  DNA adducts of chemical carcinogens. , 1995, Carcinogenesis.

[48]  S. Jentsch,et al.  DNA-protein crosslink repair: proteases as DNA repair enzymes. , 2015, Trends in biochemical sciences.

[49]  John T. Powers,et al.  ATM promotes apoptosis and suppresses tumorigenesis in response to Myc , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Ling-gang Wu,et al.  Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis , 2013, Nature Cell Biology.

[51]  C. Walker,et al.  ATM engages the TSC2/mTORC1 signaling node to regulate autophagy , 2010, Autophagy.

[52]  Lin Li,et al.  Reactive oxygen species regulation of autophagy in cancer: implications for cancer treatment. , 2012, Free radical biology & medicine.

[53]  P. Garnier,et al.  NAD+ repletion prevents PARP-1-induced glycolytic blockade and cell death in cultured mouse astrocytes. , 2003, Biochemical and biophysical research communications.

[54]  W. Roos,et al.  The inducible E3 ubiquitin ligases SIAH1 and SIAH2 perform critical roles in breast and prostate cancers. , 2015, Cytokine & growth factor reviews.

[55]  J. Hoeijmakers.  Genome maintenance mechanisms for preventing cancer , 2001, Nature.

[56]  Gangning Liang,et al.  DNA methylation screening identifies driver epigenetic events of cancer cell survival. , 2012, Cancer cell.

[57]  Bas van Steensel,et al.  TRF2 Protects Human Telomeres from End-to-End Fusions , 1998, Cell.

[58]  Lesley McGuffog,et al.  Cancer risks and mortality in heterozygous ATM mutation carriers. , 2005, Journal of the National Cancer Institute.

[59]  W. Kaiser,et al.  DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. , 2012, Cell host & microbe.

[60]  A. Kauffmann,et al.  High expression of DNA repair pathways is associated with metastasis in melanoma patients , 2008, Oncogene.

[61]  E. Rogakou,et al.  DNA Double-stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139* , 1998, The Journal of Biological Chemistry.

[62]  R A Knight,et al.  Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009 , 2005, Cell Death and Differentiation.

[63]  Yoichi Taya,et al.  Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2 , 2002, Nature Cell Biology.

[64]  Universitätsklinikum Münster,et al.  Survivin, a target to modulate the radiosensitivity of Ewing's sarcoma , 2012 .

[65]  Xuan Sun,et al.  Akt Phosphorylates and Negatively Regulates Apoptosis Signal-Regulating Kinase 1 , 2001, Molecular and Cellular Biology.

[66]  R. Hruban,et al.  Having Pancreatic Cancer with Tumoral Loss of ATM and Normal TP53 Protein Expression Is Associated with a Poorer Prognosis , 2014, Clinical Cancer Research.

[67]  Joan W. Miller,et al.  Receptor interacting protein kinases mediate retinal detachment-induced photoreceptor necrosis and compensate for inhibition of apoptosis , 2010, Proceedings of the National Academy of Sciences.

[68]  S. Haas,et al.  A general role for c-Fos in cellular protection against DNA-damaging carcinogens and cytostatic drugs. , 1997, Cancer research.

[69]  M. Christmann,et al.  MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. , 2007, DNA repair.

[70]  M. Christmann,et al.  Mouse embryonic stem cells are hypersensitive to apoptosis triggered by the DNA damage O6-methylguanine due to high E2F1 regulated mismatch repair , 2007, Cell Death and Differentiation.

[71]  J. Tschopp,et al.  PIDD death-domain phosphorylation by ATM controls prodeath versus prosurvival PIDDosome signaling. , 2012, Molecular cell.

[72]  S. Chi,et al.  XAF1 directs apoptotic switch of p53 signaling through activation of HIPK2 and ZNF313 , 2014, Proceedings of the National Academy of Sciences.

[73]  H. Tang,et al.  Reversibility of apoptosis in cancer cells , 2008, British Journal of Cancer.

[74]  D. Rubinsztein,et al.  Raised intracellular glucose concentrations reduce aggregation and cell death caused by mutant huntingtin exon 1 by decreasing mTOR phosphorylation and inducing autophagy. , 2003, Human molecular genetics.

[75]  J. Sale.  Competition, collaboration and coordination – determining how cells bypass DNA damage , 2012, Journal of Cell Science.

[76]  Wan-Wan Lin,et al.  Oxidative stress initiates DNA damager MNNG-induced poly(ADP-ribose)polymerase-1-dependent parthanatos cell death. , 2011, Biochemical pharmacology.

[77]  S. Fulda.  Cell Death and Survival Signaling in Oncogenesis , 2010, Klinische Padiatrie.

[78]  C. Prives,et al.  hCAS/CSE1L Associates with Chromatin and Regulates Expression of Select p53 Target Genes , 2007, Cell.

[79]  B. Zhivotovsky,et al.  Death through a tragedy: mitotic catastrophe , 2008, Cell Death and Differentiation.

[80]  Kun-Liang Guan,et al.  Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α , 2009, Science.

[81]  M. Malim,et al.  Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[82]  B. Epe,et al.  Wavelength dependence of oxidative DNA damage induced by UV and visible light. , 1997, Carcinogenesis.

[83]  E. Tan,et al.  Ring finger protein 146/Iduna is a Poly(ADP-ribose) polymer binding and PARsylation dependent E3 ubiquitin ligase , 2011, Cell adhesion & migration.

[84]  I. Szumiel,et al.  Signalling loops and linear pathways: NF-kappaB activation in response to genotoxic stress. , 2008, Mutagenesis.

[85]  B. Kaina,et al.  DNA damage-induced cell death: from specific DNA lesions to the DNA damage response and apoptosis. , 2013, Cancer letters.

[86]  B. Kaina,et al.  DNA damage-induced cell death by apoptosis. , 2006, Trends in molecular medicine.

[87]  John Calvin Reed,et al.  Bcl-2 family proteins and cancer , 2008, Oncogene.

[88]  Yao-Kuang Wu,et al.  Nuclear survivin expression: a prognostic factor for the response to taxane–platinum chemotherapy in patients with advanced non-small cell lung cancer , 2014, Medical Oncology.

[89]  P. Stork,et al.  Mitogen-activated Protein Kinase Phosphatases Inactivate Stress-activated Protein Kinase Pathways in Vivo* , 1997, The Journal of Biological Chemistry.

[90]  D. Baltimore,et al.  Dual roles of ATM in the cellular response to radiation and in cell growth control. , 1996, Genes & development.

[91]  John Calvin Reed,et al.  Regulation of cell death protease caspase-9 by phosphorylation. , 1998, Science.

[92]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[93]  G. Cooper,et al.  Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. , 1995, Science.

[94]  S. Lowe,et al.  Apoptosis in cancer. , 2000, Carcinogenesis.

[95]  M. D’Incalci,et al.  Proneness to UV-induced apoptosis in human fibroblasts defective in transcription coupled repair is associated with the lack of Mdm2 transactivation , 2000, Oncogene.

[96]  Kevin M. Ryan,et al.  DRAM, a p53-Induced Modulator of Autophagy, Is Critical for Apoptosis , 2006, Cell.

[97]  Z. Cheng,et al.  Cell fate decision mediated by p53 pulses , 2009, Proceedings of the National Academy of Sciences.

[98]  H. Esumi,et al.  IGF-1 phosphorylates AMPK-alpha subunit in ATM-dependent and LKB1-independent manner. , 2004, Biochemical and biophysical research communications.

[99]  K. Ryan,et al.  DRAM-1 encodes multiple isoforms that regulate autophagy , 2012, Autophagy.

[100]  Y Taya,et al.  p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis. , 2001, Molecular cell.

[101]  B. Kaina,et al.  DNA breaks and chromosomal aberrations arise when replication meets base excision repair , 2014, The Journal of cell biology.

[102]  R. Gaynor,et al.  Identification of NF-κB-regulated genes induced by TNFα utilizing expression profiling and RNA interference , 2004, Oncogene.

[103]  B. Levine,et al.  Dual Role of JNK1-mediated phosphorylation of Bcl-2 in autophagy and apoptosis regulation , 2008, Autophagy.

[104]  P. Herrlich,et al.  The mammalian UV response: mechanism of DNA damage induced gene expression. , 1994, Advances in enzyme regulation.

[105]  D Morrell,et al.  Incidence of cancer in 161 families affected by ataxia-telangiectasia. , 1991, The New England journal of medicine.

[106]  M. Bertrand,et al.  Intermediate Domain of Receptor-interacting Protein Kinase 1 (RIPK1) Determines Switch between Necroptosis and RIPK1 Kinase-dependent Apoptosis* , 2012, The Journal of Biological Chemistry.

[107]  R A Knight,et al.  Classification of cell death: recommendations of the Nomenclature Committee on Cell Death , 2005, Cell Death and Differentiation.

[108]  E. Bonmassar,et al.  AKT Is Activated in an Ataxia-Telangiectasia and Rad3-Related-Dependent Manner in Response to Temozolomide and Confers Protection against Drug-Induced Cell Growth Inhibition , 2008, Molecular Pharmacology.

[109]  K. Khanna.  Cancer risk and the ATM gene: a continuing debate. , 2000, Journal of the National Cancer Institute.

[110]  M. Christmann,et al.  Delayed c-Fos activation in human cells triggers XPF induction and an adaptive response to UVC-induced DNA damage and cytotoxicity , 2010, Cellular and Molecular Life Sciences.

[111]  R. Olson,et al.  Mechanism of adriamycin cardiotoxicity: evidence for oxidative stress. , 1981, Life sciences.

[112]  S. Jackson,et al.  Human cell senescence as a DNA damage response , 2005, Mechanisms of Ageing and Development.

[113]  J. Jiricny,et al.  DNA damage induced by temozolomide signals to both ATM and ATR: role of the mismatch repair system. , 2004, Molecular pharmacology.

[114]  L. Mayo,et al.  Phosphorylation of Human p53 at Serine 46 Determines Promoter Selection and whether Apoptosis Is Attenuated or Amplified* , 2005, Journal of Biological Chemistry.

[115]  S. R. Datta,et al.  Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery , 1997, Cell.

[116]  R. Mirzayans,et al.  Role of p16INK4A in Replicative Senescence and DNA Damage-Induced Premature Senescence in p53-Deficient Human Cells , 2012, Biochemistry research international.

[117]  S. Miyamoto,et al.  Sequential Modification of NEMO/IKKγ by SUMO-1 and Ubiquitin Mediates NF-κB Activation by Genotoxic Stress , 2003, Cell.

[118]  I. Germano,et al.  Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. , 2003, Cancer research.

[119]  G. Réz,et al.  Cellular autophagic capacity is highly increased in azaserine-induced premalignant atypical acinar nodule cells. , 1999, Carcinogenesis.

[120]  D. Ferrari,et al.  Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. , 2002, Molecular biology of the cell.

[121]  T. Cremer,et al.  Senescence in vitro and ionising radiations—the human diploid fibroblast model , 1981, Mechanisms of Ageing and Development.

[122]  S. Lowe,et al.  Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy , 2004, Nature.

[123]  Z. Oltvai,et al.  Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[124]  David J. Chen,et al.  Akt Promotes Post-Irradiation Survival of Human Tumor Cells through Initiation, Progression, and Termination of DNA-PKcs–Dependent DNA Double-Strand Break Repair , 2012, Molecular Cancer Research.

[125]  M. Offermann,et al.  Apoptosis Induced by the Toll-Like Receptor Adaptor TRIF Is Dependent on Its Receptor Interacting Protein Homotypic Interaction Motif1 , 2005, The Journal of Immunology.

[126]  D. Meek,et al.  Critical role for p53-serine 15 phosphorylation in stimulating transactivation at p53-responsive promoters , 2014, Nucleic acids research.

[127]  S. Hilsenbeck,et al.  Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53 , 1997, Molecular and cellular biology.

[128]  Uri Alon,et al.  Dynamics of the p53-Mdm2 feedback loop in individual cells , 2004, Nature Genetics.

[129]  G. Reifenberger,et al.  MGMT promoter methylation in malignant gliomas: ready for personalized medicine? , 2010, Nature Reviews Neurology.

[130]  T. Stankovic,et al.  ATM Mutations in Sporadic Lymphoid Tumours , 2002, Leukemia & lymphoma.

[131]  K. W. Kim,et al.  Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells. , 2006, Cancer research.

[132]  Jun Li,et al.  A Two-Step Mechanism for Cell Fate Decision by Coordination of Nuclear and Mitochondrial p53 Activities , 2012, PloS one.

[133]  Yoshio Miki,et al.  Protein Kinase C δ Regulates Ser46 Phosphorylation of p53 Tumor Suppressor in the Apoptotic Response to DNA Damage* , 2006, Journal of Biological Chemistry.

[134]  T. Helleday.  Homologous recombination in cancer development, treatment and development of drug resistance. , 2010, Carcinogenesis.

[135]  Wei Zhang,et al.  DNA damage-induced phosphorylation of p53 at serine 20 correlates with p21 and Mdm-2 induction in vivo , 2000, Oncogene.

[136]  V. Bohr,et al.  Human Embryonic Stem Cells Have Enhanced Repair of Multiple Forms of DNA Damage , 2008, Stem cells.

[137]  D. Broccoli,et al.  Human telomeres contain two distinct Myb–related proteins, TRF1 and TRF2 , 1997, Nature Genetics.

[138]  L. Mayo,et al.  A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[139]  R. Korneluk,et al.  cIAP1 and cIAP2 limit macrophage necroptosis by inhibiting Rip1 and Rip3 activation , 2012, Cell Death and Differentiation.

[140]  D. Lane,et al.  Transcription — guarding the genome by sensing DNA damage , 2004, Nature Reviews Cancer.

[141]  Xun Hu,et al.  Targeting the Weak Point of Cancer by Induction of Necroptosis , 2007, Autophagy.

[142]  H. Nakano,et al.  The death domain kinase RIP has an essential role in DNA damage-induced NF-kappa B activation. , 2003, Genes & development.

[143]  H. Bernstein,et al.  DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. , 2002, Mutation research.

[144]  R. Xavier,et al.  CASPASE 8 inhibits programmed necrosis by processing CYLD , 2011, Nature Cell Biology.

[145]  S. Baylin,et al.  Tumor Suppressor HIC1 Directly Regulates SIRT1 to Modulate p53-Dependent DNA-Damage Responses , 2005, Cell.

[146]  L. Galluzzi,et al.  Cell Death Signaling and Anticancer Therapy , 2011, Front. Oncol..

[147]  B. Wasylyk,et al.  Transcription Abnormalities Potentiate Apoptosis of Normal Human Fibroblasts , 1997, Molecular medicine.

[148]  Mihalis I Panayiotidis,et al.  DNA damage induced by endogenous aldehydes: current state of knowledge. , 2011, Mutation research.

[149]  M. Bjørås,et al.  Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein. , 2010, Blood.

[150]  J. Schimenti,et al.  Role of DNA damage response pathways in preventing carcinogenesis caused by intrinsic replication stress , 2013, Oncogene.

[151]  L. Wiesmüller,et al.  NF-κB regulates DNA double-strand break repair in conjunction with BRCA1–CtIP complexes , 2011, Nucleic acids research.

[152]  G. Mills,et al.  ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS , 2010, Proceedings of the National Academy of Sciences.

[153]  B. Kaina,et al.  DNA double-strand breaks trigger apoptosis in p53-deficient fibroblasts. , 2001, Carcinogenesis.

[154]  B. Kaina,et al.  Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/XPC-mediated DNA repair , 2014, Oncogene.

[155]  J C Reed,et al.  IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. , 1998, Cancer research.

[156]  T. Mak,et al.  Regulation of PTEN transcription by p53. , 2001, Molecular cell.

[157]  Da-Qing Yang,et al.  Functional switching of ATM: sensor of DNA damage in proliferating cells and mediator of Akt survival signal in post-mitotic human neuron-like cells , 2012, Chinese journal of cancer.

[158]  E. Siles,et al.  ROS-induced DNA damage and PARP-1 are required for optimal induction of starvation-induced autophagy , 2012, Cell Research.

[159]  Jiri Bartek,et al.  An Oncogene-Induced DNA Damage Model for Cancer Development , 2008, Science.

[160]  T. Dawson,et al.  Mitochondrial and Nuclear Cross Talk in Cell Death , 2008, Annals of the New York Academy of Sciences.

[161]  M. Christmann,et al.  Translesion polymerase η is upregulated by cancer therapeutics and confers anticancer drug resistance. , 2014, Cancer research.

[162]  A. Yasui,et al.  DNA damage in transcribed genes induces apoptosis via the JNK pathway and the JNK-phosphatase MKP-1 , 2005, Oncogene.

[163]  J. Bartek,et al.  DNA damage checkpoints: from initiation to recovery or adaptation. , 2007, Current opinion in cell biology.

[164]  G. de Murcia,et al.  PARP-1 is involved in autophagy induced by DNA damage , 2009, Autophagy.

[165]  E. Gilson,et al.  TRF2 inhibition promotes anchorage-independent growth of telomerase-positive human fibroblasts , 2006, Oncogene.

[166]  K. Cimprich,et al.  Causes and consequences of replication stress , 2013, Nature Cell Biology.

[167]  A. Fraser,et al.  Genome-wide RNAi identifies p53-dependent and -independent regulators of germ cell apoptosis in C. elegans , 2004, Cell Death and Differentiation.

[168]  Pei-Ming Yang,et al.  Life or death? Autophagy in anticancer therapies with statins and histone deacetylase inhibitors , 2011, Autophagy.

[169]  C. Blattner,et al.  p53 stabilization in response to DNA damage requires Akt/PKB and DNA-PK , 2008, Proceedings of the National Academy of Sciences.

[170]  M. Christmann,et al.  Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks. , 2007, Cancer research.

[171]  M. Christmann,et al.  Survival and Death Strategies in Glioma Cells: Autophagy, Senescence and Apoptosis Triggered by a Single Type of Temozolomide-Induced DNA Damage , 2013, PloS one.

[172]  Yuhki Yanase,et al.  Germline mutation in ATR in autosomal- dominant oropharyngeal cancer syndrome. , 2012, American journal of human genetics.

[173]  P. Degan,et al.  Terminally differentiated muscle cells are defective in base excision DNA repair and hypersensitive to oxygen injury , 2007, Proceedings of the National Academy of Sciences.

[174]  Zhaohui Xu,et al.  Functional interaction between FOXO3a and ATM regulates DNA damage response , 2009, Nature Cell Biology.

[175]  Jung Sup Lee,et al.  Caspase-2 cleaves DNA fragmentation factor (DFF45)/inhibitor of caspase-activated DNase (ICAD). , 2007, Archives of biochemistry and biophysics.

[176]  K. Sakaguchi,et al.  Phosphorylation of human p53 by p38 kinase coordinates N‐terminal phosphorylation and apoptosis in response to UV radiation , 1999, The EMBO journal.

[177]  N. de Wind,et al.  The Translesion Polymerase Rev3L in the Tolerance of Alkylating Anticancer Drugs , 2009, Molecular Pharmacology.

[178]  B. Garicochea,et al.  Monitoring Survivin Expression in Cancer: Implications for Prognosis and Therapy , 2013, Molecular Diagnosis & Therapy.

[179]  Q Cheng,et al.  NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[180]  Yusuke Nakamura,et al.  p53AIP1, a Potential Mediator of p53-Dependent Apoptosis, and Its Regulation by Ser-46-Phosphorylated p53 , 2000, Cell.

[181]  Ailan Guo,et al.  The function of PML in p53-dependent apoptosis , 2000, Nature Cell Biology.

[182]  M. Christmann,et al.  c-Fos is required for excision repair of UV-light induced DNA lesions by triggering the re-synthesis of XPF , 2006, Nucleic acids research.

[183]  M. Bertrand,et al.  TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members , 2011, Cell Death and Disease.

[184]  Wan-Wan Lin,et al.  Energy adaptive response during parthanatos is enhanced by PD98059 and involves mitochondrial function but not autophagy induction. , 2014, Biochimica et biophysica acta.

[185]  M. Christmann,et al.  O(6)-Methylguanine-DNA methyltransferase (MGMT) in normal tissues and tumors: enzyme activity, promoter methylation and immunohistochemistry. , 2011, Biochimica et biophysica acta.

[186]  J. Cadet,et al.  Oxidatively generated complex DNA damage: tandem and clustered lesions. , 2012, Cancer letters.

[187]  P. Nicotera,et al.  Intracellular Adenosine Triphosphate (ATP) Concentration: A Switch in the Decision Between Apoptosis and Necrosis , 1997, The Journal of experimental medicine.

[188]  Masaaki Adachi,et al.  p53‐inducible Wip1 phosphatase mediates a negative feedback regulation of p38 MAPK‐p53 signaling in response to UV radiation , 2000, The EMBO journal.

[189]  Alexander Bürkle,et al.  Poly(ADP‐ribose) , 2005, The FEBS journal.

[190]  H. O’Hagan,et al.  Induction of ser15 and lys382 modifications of p53 by blockage of transcription elongation , 2001, Oncogene.

[191]  V. Dawson,et al.  Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. , 1998, Trends in pharmacological sciences.

[192]  V. Skulachev.  Bioenergetic aspects of apoptosis, necrosis and mitoptosis , 2006, Apoptosis.

[193]  J. Campisi,et al.  Persistent DNA damage signaling triggers senescence-associated inflammatory cytokine secretion , 2009, Nature Cell Biology.

[194]  A. Kimchi,et al.  Autophagy as a cell death and tumor suppressor mechanism , 2004, Oncogene.

[195]  B. Moss,et al.  A Role for Tumor Necrosis Factor Receptor-2 and Receptor-interacting Protein in Programmed Necrosis and Antiviral Responses* , 2003, Journal of Biological Chemistry.

[196]  D. Altieri.  Survivin and IAP proteins in cell-death mechanisms. , 2010, The Biochemical journal.

[197]  P. Hanawalt,et al.  Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[198]  M. Christmann,et al.  Transcriptional regulation of human DNA repair genes following genotoxic stress: trigger mechanisms, inducible responses and genotoxic adaptation , 2013, Nucleic acids research.

[199]  Xin Lu,et al.  ASPP: a new family of oncogenes and tumour suppressor genes , 2007, British Journal of Cancer.